Differential effects of acute and subacute HA-966 treatment on storage and release of striatal dopamine
- 1 December 1979
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 60 (2-3), 153-161
- https://doi.org/10.1016/0014-2999(79)90214-0
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Significance of dopamine metabolites in the evaluation of drugs acting on dopaminergic neuronesEuropean Journal of Pharmacology, 1978
- Haloperidol inhibits the disappearance of acidic dopamine metabolites from rat striatumJournal of Pharmacy and Pharmacology, 1978
- Rapid development of hypersensitivity of striatal dopamine receptors induced by alpha-methylparatyrosine and its prevention by protein synthesis inhibitorsLife Sciences, 1977
- The dynamics of dopamine metabolism in various regions of rat brainEuropean Journal of Pharmacology, 1977
- Dopaminergic neurons: Reversal of effects elicited by ?-butyrolactone by stimulation of the nigro-neostriatal pathwayNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1976
- Differential actions of dopamine agonists and antagonists on the ?-butyrolactone-induced increase in mouse brain dopaminePsychopharmacology, 1976
- Evidence for a receptor-mediated feedback control of striatal tyrosine hydroxylase activityJournal of Pharmacy and Pharmacology, 1972
- 1‐Hydroxy‐3‐amino‐pyrrolidone‐2 (HA‐966): a new GABA‐like compound, with potential use in extrapyramidal diseasesBritish Journal of Pharmacology, 1971
- The influence of 1-hydroxy-3-amino-pyrrolidinone-2 (HA-966) on dopamine metabolism in the rat corpus striatumEuropean Journal of Pharmacology, 1971
- Importance of nervous impulse flow for the neuroleptic induced increase in amine turnover in central dopamine neuronsEuropean Journal of Pharmacology, 1971